WINDTREE THERAPEUTICS

windtree-therapeutics-logo

Windtree Therapeutics (formerly Discovery Laboratories) is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfact... ant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies.

#SimilarOrganizations #People #Financial #Event #Website #More

WINDTREE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Wellness

Founded:
1992-11-01

Address:
Warrington, Pennsylvania, United States

Country:
United States

Website Url:
http://www.windtreetx.com

Total Employee:
101+

Status:
Active

Contact:
(215) 488-9300

Email Addresses:
[email protected]

Total Funding:
128.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

arvinas-logo

Arvinas

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

ipsen-logo

Ipsen

Ipsen develops and markets medications used in oncology, neuroscience and rare diseases along with consumer healthcare products.

merrimack-pharmaceuticals-logo

Merrimack Pharmaceuticals

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

radius-health-logo

Radius Health

Radius Health develops drug therapies for osteoporosis and women’s health.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

x-cell-medical-logo

X-Cell Medical

X-Cell Medical developing next-generation solutions for restenosis and other cardiovascular clinical applications.


Current Advisors List

rob-scott_image

Rob Scott Board Member @ Windtree Therapeutics
Board_member
2021-02-01

bruce-a-peacock_image

Bruce A. Peacock Board of Directors @ Windtree Therapeutics
Board_member

Current Employees Featured

not_available_image

John A. Tattory
John A. Tattory Chief Financial Officer @ Windtree Therapeutics
Chief Financial Officer

randall-white_image

Randall White
Randall White VP, Clinical Program Management @ Windtree Therapeutics
VP, Clinical Program Management
2021-08-01

craig-fraser_image

Craig Fraser
Craig Fraser CEO & Director @ Windtree Therapeutics
CEO & Director
2016-01-01

john-hamill_image

John Hamill
John Hamill SVP & Chief Financial Officer @ Windtree Therapeutics
SVP & Chief Financial Officer
2020-07-01

Founder


masa-nakatsu_image

Masa Nakatsu

Stock Details


Company's stock symbol is OTCQB:WINT

Investors List

vms-group_image

VMS Asset Management

VMS Asset Management investment in Post-IPO Equity - Windtree Therapeutics

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Windtree Therapeutics

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Windtree Therapeutics

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Windtree Therapeutics

deerfield_image

Deerfield

Deerfield investment in Post-IPO Debt - Windtree Therapeutics

Key Employee Changes

Date New article
2020-07-20 Windtree names Hamill as new CFO

Official Site Inspections

http://www.windtreetx.com Semrush global rank: 5.1 M Semrush visits lastest month: 1.61 K

  • Host name: 172.67.141.35
  • IP address: 172.67.141.35
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Windtree Therapeutics"

Windtree Therapeutics, Inc. | LinkedIn

Windtree Therapeutics is a global, clinical-stage, biopharmaceutical and medical device company focused on the development of novel therapeutics intended to address significant unmet …See details»

Windtree Therapeutics - Wikipedia

Windtree Therapeutics, Inc. (formerly Discovery Laboratories) is an American company which was set up in 1992 and now is based in Warrington, Pennsylvania, developing drug products (pulmonary medicine) for patients with respiratory disease. The company joined an alliance with Laboratorios del Dr. Esteve, S.A. In 2016, Discovery Laboratories changed name to Windtree Therapeutics, Inc. See details»

Windtree Announces Leadership Transition Plan With Industry …

Nov 14, 2024 Jed Latkin to transition to CEO. WARRINGTON, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: …See details»

Windtree Therapeutics Company Profile | Management and

Www.windtreetx.com Windtree Therapeutics Profile and History Founded in 1992, Windtree Therapeutics is a specialty biotechnology company focused on advancing respiratory critical …See details»

Windtree Therapeutics, Inc. - Company Profile & Staff

Windtree Therapeutics is a global, clinical-stage, biopharmaceutical and medical device company focused on the development of novel therapeutics intended to address significant unmet …See details»

Get in touch - WINDTREE THERAPEUTICS

4953 Vine Street San Diego, CA 92465. Phone. (815) 555-5555See details»

Windtree Therapeutics - Overview, News & Similar companies

Windtree Therapeutics contact info: Phone number: (215) 488-9300 Website: www.windtreetx.com What does Windtree Therapeutics do? Founded in 1992, Windtree …See details»

Windtree Therapeutics, Inc. (WINT) - Yahoo Finance

See the company profile for Windtree Therapeutics, Inc. (WINT) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»

Windtree Therapeutics Announces Positive Istaroxime Phase 2 …

WARRINGTON, Pa. , Sept. 28, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage …See details»

Windtree Therapeutics CEO and Key Executive Team | Craft.co

Windtree Therapeutics's SVP, Chief Development Officer is Steve Simonson. Other executives include Eric Curtis, COO; Craig Fraser, CEO, President and Director and 6 others. See the full …See details»

Windtree Therapeutics - PitchBook

Windtree Therapeutics General Information Description. Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for …See details»

Windtree Therapeutics Announces Virtual Investor Day …

Sep 26, 2024 New Istaroxime Phase 2b clinical results to be presented by Windtree and top cardiology expert Review of cardiogenic shock and other programs, including Windtree’s …See details»

Windtree Therapeutics, Inc. Information - RocketReach

Windtreetx.com; View Similar People. Related Companies Synthes Orthopedics. 9 $2.4b Community Veterinary Partners. 172 $440.4m Fisher Scientfic. 159 $96.7m BioTelemetry, Inc. …See details»

Windtree Therapeutics - Craft

Oct 29, 2024 Windtree Therapeutics has 4 employees at their 1 location and $198 k in annual revenue in FY 2019. See insights on Windtree Therapeutics including office locations, …See details»

Windtree Therapeutics, Inc.’s Post - LinkedIn

Today our CEO, Craig Fraser, will present at the Biotechnology Innovation Organization International Convention at 3pm PDT / 6pm EDT in Theater 1. Craig will be discussing the …See details»

Craig Fraser - CEO & Director @ Windtree Therapeutics

Greater Philadelphia Area Companies With Less Than $10M in Revenue (Top 10K)See details»

Windtree’s Competitors, Revenue, Number of Employees, Funding …

Windtree’s Profile, Revenue and Employees. Windtree is a Pennsylvania-based biotechnology company that researches and develops novel therapeutics for the treatment of cardiovascular …See details»

Windtree Therapeutics Announces Pricing of $20.0 Million Public ...

May 20, 2020 For more information, please visit the Company's website at www.windtreetx.com. Forward-Looking Statements This press release contains forward-looking statements within …See details»

Windtree Announces Positive Phase 2b Topline Clinical Results …

Sep 30, 2024 Istaroxime treatment significantly improved systolic blood pressure as well as cardiac output and renal function without increasing heart rate or clinically ...See details»

Working at Windtree Therapeutics - Zippia

Learn about working at Windtree Therapeutics from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more.See details»

linkstock.net © 2022. All rights reserved